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Systemic sclerosis (SSc) is a connective tissue disease 
manifest by fibrotic tissue changes, microvascular disease, 
and autoimmune abnormalities. The prevalence of differ-
ent neurological manifestations in SSc has ranged from 
0.8%1 to 18.5%2 according to the adopted criteria.
Trigeminal sensory neuropathy (TSN) causes numb-
ness in the mandibular or maxillary divisions of the nerve 
in about 2/3 of the cases, and in the distribution of all 
divisions in the remaining cases. The sensory abnormal-
ities evolve slowly and usually spread contralaterally in 
an asymmetric pattern. The numbness may be accompa-
nied by burning dysesthesia that is distinct from trigem-
inal neuralgia3.
TSN is an infrequent complication of SSc. Although 
epidemiological studies are scarce, the prevalence of TSN 
associated with SSc in the largest series available was 4%4. 
A fairly diligent review of the literature revealed no pre-
vious report of TSN as a complication of SSc in Brazil. We 
present three cases of such association.
CASES
Case 1
A 42-year-old male had presented progressive facial hypoes-
thesia and dysesthesia for the last three years and was diagnosed 
with the diffuse form of SSc two years ago. At his first neuro-
logical evaluation, he had sclerodermic fascies, sclerodactyly, 
Raynaud’s phenomenon, bilateral facial and lingual hypoesthe-
sia, left hemifacial dysesthesia, and an absent left corneal reflex. 
Nailfold capillaroscopy was performed and showed devascular-
ization and ectasias. ANA was positive (1/640) and anti-RNP was 
also positive. Nerve conduction studies (NCS) revealed sensory 
myelinic polyneuropathy in all limbs and face. Blink reflex stud-
ies (BRS) demonstrated absent responses on both sides to left 
supraorbital nerve stimulation. Electromyography (EMG) was 
normal. He was on methotrexate and prednisone without im-
provement of the TSN. Gabapentin 800 mg daily and nortryp-
tilin 100 mg daily were introduced with only a partial response 
at their maximum tolerable doses.
Case 2
A 47-year-old female had presented Raynaud’s phenomenon 
and arthritis in her hands for the last three years and was feel-
ing progressive numbness in the inferior half of the face for the 
last two years, without any previous diagnosis. At her first neu-
rological evaluation, she had sclerodermic fascies, sclerodactyly, 
hypoesthesia in the maxillary and mandibular divisions territory 
bilaterally. ANA was positive (1/80), an esophagogram showed 
an increased esophageal caliber and a thoracic tomography con-
firmed this finding and revealed signs of pulmonary fibrosis. All 
electrophysiological studies performed (NCS, BRS, EMG) were 
normal. She had never been on medication for TSN or SSc yet.
Case 3
A 50-year-old female had presented hypoesthesia only in 
the maxillary division of the right trigeminal nerve about three 
years before her first neurological evaluation. Six months later, 
she started presenting hypoesthesia in the mandibullary division, 
effort dyspnea, Raynaud’s phenomenon and myalgia. She was di-
agnosed with SSc in overlap with myositis 10 months before our 
first evaluation. At that time, she presented digital ulcers, sclero-
dactyly, right hemifacial and lingual hypoesthesia, and an absent 
right corneal reflex. NCS were normal. BRS demonstrated absent 
responses on both sides to right supraorbital nerve stimulation. 
EMG showed polyphasic, low amplitude, and short duration ac-
tion potentials of the motor units within the orbiculari oris mus-
cles. She had to stop methotrexate treatment due to adverse ef-
fects, and then she was started on prednisone 20 mg daily and 
amitryptiline 50 mg daily without improvement.
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In all three cases, cranial magnetic resonance imaging (MRI) 
was normal and a written informed consent was obtained.
DISCUSSION
The increased likelihood of TSN to affect females with 
SSc in their fourth and fifth decade of life indicated in 
our small report is probably due to the prevalence pat-
tern of SSc in the general population as shown in a large 
epidemiological study5. Furthermore, there was no signif-
icant difference in the sex distribution between the pa-
tients with TSN and those without TSN in the largest se-
ries available4.
Alike previous case reports, our series indicate that 
TSN complaints usually begin with the onset of facial 
numbness, with or without pain or paresthesias. This 
symptom may precede the first indication of clinically 
active SSc, but generally follows the latter by a matter 
of months. The associated SSc is not usually attended by 
rapidly progressive life-threatening neurologic or system-
ic disease4,6.
In our three patients with TSN, the facial sensory def-
icit was prominent. Similarly to what is publicized in the 
literature, the initial involvement was confined to the 
distal portions of the second and third divisions of the 
trigeminal nerve. Although a corneal reflex was absent 
in two patients at the time of neurological examination, 
the facial paresthesias and sensory deficit were more ap-
parent in the perioral region. The motor division of the 
trigeminal nerve was spared in all patients3,4,7,8.
BRS is the standard test to assess trigeminal function. 
Although it demonstrated an afferent pattern of abnor-
mal responses in two patients (Cases 1 and 3), normal re-
sults of BRS in TSN (as seen in Case 2) were reported pre-
viously.9 TSN has been observed most frequently in CREST 
syndrome (calcinosis, Raynaud’s phenomenon, esopha-
geal dysmotility, sclerodactyly and telangiectasia) or SSc 
in overlap with other disorders, like myositis. The antinu-
clear and anti-RNP antibodies have frequently been found 
in SSc with TSN.4
The distribution of sensory loss found in SSc with TSN 
is not consistent with the somatotopic arrangement of 
the nucleus of the spinal tract of the trigeminal nerve 
and almost invariably fails to respect trigeminal division-
al and cutaneous nerve territories. It is speculated that 
the disease process lies in the Gasserian ganglion or sen-
sory root of the trigeminal nerve, as reflected on MRI by 
abnormal contrast uptake and slight enlargement of its 
pre-ganglionic segment, which resolves with the resolu-
tion of the early edematous stage of SSc10. In most in-
stances, TSN does not respond to antineuralgic or immu-
nosuppressive therapy8.
We report three cases of TSN associated with SSc. We 
would like to emphasize that the involvement of the ner-
vous system may occur in SSc and it is not so uncommon. 
TSN is probably underdiagnosed in these patients as it can 
easily be confused with symptoms of sclerotic skin stiff-
ness. Careful and repeated investigation of an underlying 
illness should be required as TSN may antedate the active 
phase of many connective tissue diseases such as SSc.
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